Cns Pharmaceuticals Inc (NASDAQ: CNSP) on Monday, soared 9.68% from the previous trading day, before settling in for the closing price of $0.13. Within the past 52 weeks, CNSP’s price has moved between $0.10 and $137.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
With a float of $32.84 million, this company’s outstanding shares have now reached $33.45 million.
The extent of productivity of a business whose workforce counts for 5 workers is very important to gauge. In terms of profitability, gross margin is 46.21%, operating margin of -251276.17%, and the pretax margin is -251077.43%.
Cns Pharmaceuticals Inc (CNSP) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cns Pharmaceuticals Inc is 1.81%, while institutional ownership is 0.43%. The most recent insider transaction that took place on Feb 01 ’24, was worth 10,000. In this transaction Director of this company bought 33,333 shares at a rate of $0.30, taking the stock ownership to the 43,006 shares. Before that another transaction happened on Feb 01 ’24, when Company’s Director bought 33,333 for $0.30, making the entire transaction worth $10,000. This insider now owns 33,458 shares in total.
Cns Pharmaceuticals Inc (CNSP) Latest Financial update
As on 9/30/2022, Multinational firm has announced its last quarter scores, in which it reported -2.1 earnings per share (EPS) for the period topping the consensus outlook (set at -3.3) by 1.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Trading Performance Indicators
Cns Pharmaceuticals Inc (CNSP) is currently performing well based on its current performance indicators. A quick ratio of 0.31 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -128.91, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Cns Pharmaceuticals Inc (CNSP)
The latest stats from [Cns Pharmaceuticals Inc, CNSP] show that its last 5-days average volume of 139.07 million was superior to 5.27 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 9.45%. Additionally, its Average True Range was 0.03.
During the past 100 days, Cns Pharmaceuticals Inc’s (CNSP) raw stochastic average was set at 0.60%, which indicates a significant decrease from 11.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 114.34% in the past 14 days, which was lower than the 215.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1431, while its 200-day Moving Average is $8.0591. Now, the first resistance to watch is $0.1528. This is followed by the second major resistance level at $0.1607. The third major resistance level sits at $0.1717. If the price goes on to break the first support level at $0.1339, it is likely to go to the next support level at $0.1229. The third support level lies at $0.1150 if the price breaches the second support level.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Key Stats
Market capitalization of the company is 4.85 million based on 1,443K outstanding shares. Right now, sales total 0 K and income totals -18,850 K. The company made 0 K in profit during its latest quarter, and -2,530 K in sales during its previous quarter.
